Brief: Tianda Pharmaceuticals Posts FY Profit Attributable Of HK$10 Mln
28/06/2018 15:28
June 28 (Reuters) - Tianda Pharmaceuticals Ltd 0455.HK :
* FY REVENUE HK$361.6 MILLION, UP 84.9%
* FINAL DIVIDEND OF HK0.35 CENTS PER SHARE
* FY PROFIT ATTRIBUTABLE HK$10 MILLION VERSUS HK$12.4
MILLION
Source text for Eikon: ID:nHKS4mNkPZ
Further company coverage: 0455.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianda Pharmaceuticals
See all newsBrief: Tianda Pharmaceuticals Says Loss Attributable Expected To Increase To Hk$61 Million For FY
Brief: Tianda Pharmaceuticals Clarifies On Fraudulent Fund Raising Scams
Brief: Tianda Pharmaceuticals Sees Loss Attributable For Interim Period Increase To Not Less Than HK$27 Mln
Brief: Tianda Pharmaceuticals Says Unit Granted Drug Registration Approval Of Ibuprofen Suspension By NMPA
Brief: Tianda Pharmaceuticals Says Drug Registration Approval Of "Nicorandil For Injection" By NMPA